withanone and withaferin-a are unable to interact with transmembrane protease serine 2 and block entry of sars-cov-2 into cells
withanone and withaferin-a are unable to interact with transmembrane protease serine 2 and block entry of sars-cov-2 into cells
withanone and withaferin-a are predicted to interact with transmembrane protease serine 2 (tmprss2) and block entry of sars-cov-2 into cells all authors vipul kumar, jaspreet kaur dhanjal, priyanshu bhargava, ashish kaul, jia wang, huayue zhang, sunil c. kaul, renu wadhwa & durai sundar https://doi.org/10.1080/07391102.2020.1775704 ", "recently, sars-cov-2 was shown to use the ace2 receptor for entry and the serine protease tmprss2 for s protein priming.", "camostat mesylate (a serine protease inhibitor), well documented for the treatment of cancer, pancreatitis and liver fibrosis, has recently been shown to inhibit tmprss2 and entry of sars-cov-2 virus into the cells (hoffmann et al., 2020)."


































)